Investors Opt for P...
Health Care: Drugs
Advanced Life Sciences Holdings Inc. (ADLS: OTC)
$0.06 0.00 | 0.00%
02/08/12 - 10:55 AM ET
2.10K / 0.00
Vol / Avg. Vol:0.06 / 0.06
Open / Prev. Close:0.06 - 0.06
Today's Range:0.02 - 0.75
52 Wk Range:0.00%
Performance YTD:TheStreet Rating:
Portfolios with ADLS
- Portfolio NameUser Type
- ContributorBarron's Insider Purchases ...
- UserSwine Flue Stocks
- Userrisky risky risky
- UserAlycia's Speculative Stocks
- UserElbel's portfolio
- Userwhywhywhyme Wishful Thinking
- Userartemus portfolio I
- Usersamroll Portfolio 1
- Usermikegrunwald Portfolio 1
- Userttowles Portfolio 1
Latest ADLS Headlines from TheStreet
- Hollis-Eden Namesake Fired 'For Cause' 03.24.09 | 01:03 am
- Health Winners & Losers: Johnson & Johnson 10.01.08 | 04:10 pm
- Advanced Life, Wyeth Ink Marketing Deal 10.01.08 | 10:10 am
- Friday's Small-Cap Winners & Losers 01.18.08 | 03:01 pm
- Tuesday's Health Winners & Losers 12.11.07 | 02:12 pm
- Biotech Notebook: Medarex, Panacos, Advanced Life 12.11.07 | 01:12 pm
- Feuerstein's Biotech-Stock Mailbag 12.01.07 | 12:12 pm
- Thursday's Health Winners & Losers 11.15.07 | 03:11 pm
- Tuesday's Small-Cap Winners & Losers 08.28.07 | 04:08 pm
- Wednesday's Health Winners & Losers 08.06.07 | 09:08 pm
Press Releases for ADLS
- Advanced Life Sciences Cancels Annual Meeting Of Shareholders - PR Newswire 05.20.11 | 05:05 pm
- Advanced Life Sciences Suspends Operations - PR Newswire 05.05.11 | 05:05 pm
- Advanced Life Sciences Ticker Symbol Reverts Back To 'ADLS.OB' - PR Newswire 04.27.11 | 08:04 am
- Advanced Life Sciences To Host 2010 Fourth Quarter And Full-Year Financial Results Conference Call And Webcast - PR Newswire 03.17.11 | 09:03 am
- Advanced Life Sciences To Present At The Biotech Showcase⢠2011 Conference - PR Newswire 01.04.11 | 09:01 am
- Advanced Life Sciences To Explore Strategic Alternatives To Maximize Shareholder Value - PR Newswire 01.03.11 | 08:01 am
- Dawson James Initiates Research Coverage Of Advanced Life Sciences - PR Newswire 12.02.10 | 09:12 am
- Advanced Life Sciences Applies For FDA Orphan Drug Designation For ALS-886 To Treat Acute Lung Injury - PR Newswire 11.18.10 | 08:11 am
- Advanced Life Sciences Submits Full Proposal To NIAID For Development Of Intravenous Formulation Of Restanza As A Biodefense Countermeasure - PR Newswire 11.09.10 | 08:11 am
- Advanced Life Sciences To Host 2010 Third Quarter Financial Results Conference Call And Webcast - PR Newswire 11.05.10 | 11:11 am
Partner Headlines for ADLS
